OnKure Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
OnKure Therapeutics, Inc. has filed 399 SEC EDGAR filings since 08 Jan 2018

SEC filing history

Showing 326-350 of 399 matching filings.

Per page
25
Current page
14
3

FORM 3 SUBMISSION

Filing date
14 Oct 2021
Reporting date
11 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Aug 2021
Reporting date
25 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Aug 2021
Reporting date
25 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Aug 2021
Reporting date
25 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jul 2021
Reporting date
14 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jul 2021
Reporting date
14 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jul 2021
Reporting date
08 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Jun 2021
Reporting date
21 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jun 2021
Reporting date
08 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2021
Reporting date
03 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2021
Reporting date
28 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 May 2021
Reporting date
26 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
26 May 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40315

8-K

Filing date
14 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92480

NEW ENTERPRISE ASSOCIATES 15, L.P. / RENEO PHARMACEUTICALS, INC. -- SCHEDULE 13D

Filing date
23 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92480

SC 13D

Filing date
20 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92480

SC 13D

Filing date
19 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .